AIMP1 Gene Leukodystrophy hypomyelinating type 3 Genetic Test
Components:
Price: 4400.0 AED
Sample Condition: Blood
Report Delivery: 3 to 4 Weeks
Method: NGS Technology
Test Type: Neurological Disorders
Doctor: Neurologist
Test Department: Genetics
Pre Test Information: Clinical History of Patient who is going for AIMP1 Gene Leukodystrophy hypomyelinating type 3 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with AIMP1 Gene Leukodystrophy hypomyelinating type 3.
Test Details:
The AIMP1 gene is associated with a rare genetic disorder called Leukodystrophy hypomyelinating type 3. This disorder affects the myelin, which is the protective covering of nerve fibers in the brain and spinal cord. AIMP1 gene mutations can lead to abnormal development and maintenance of myelin, resulting in neurological symptoms.
NGS (Next-Generation Sequencing) Genetic Testing is a method used to analyze the DNA sequence of an individual’s genes. It can detect mutations or variations in specific genes, such as the AIMP1 gene, that may be responsible for a particular genetic disorder. NGS technology allows for the analysis of multiple genes simultaneously, providing a comprehensive assessment of an individual’s genetic profile.
Therefore, an AIMP1 gene NGS genetic test would involve sequencing the DNA of an individual to identify any mutations or variations in the AIMP1 gene that may be associated with Leukodystrophy hypomyelinating type 3. This test can help with the diagnosis, prognosis, and potential treatment options for individuals suspected of having this rare genetic disorder.
Test Name | AIMP1 Gene Leukodystrophy hypomyelinating type 3 Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Neurological Disorders |
Doctor | Neurologist |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for AIMP1 Gene Leukodystrophy hypomyelinating type 3 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with AIMP1 Gene Leukodystrophy hypomyelinating type 3 |
Test Details | The AIMP1 gene is associated with a rare genetic disorder called Leukodystrophy hypomyelinating type 3. This disorder affects the myelin, which is the protective covering of nerve fibers in the brain and spinal cord. AIMP1 gene mutations can lead to abnormal development and maintenance of myelin, resulting in neurological symptoms. NGS (Next-Generation Sequencing) Genetic Testing is a method used to analyze the DNA sequence of an individual’s genes. It can detect mutations or variations in specific genes, such as the AIMP1 gene, that may be responsible for a particular genetic disorder. NGS technology allows for the analysis of multiple genes simultaneously, providing a comprehensive assessment of an individual’s genetic profile. Therefore, an AIMP1 gene NGS genetic test would involve sequencing the DNA of an individual to identify any mutations or variations in the AIMP1 gene that may be associated with Leukodystrophy hypomyelinating type 3. This test can help with the diagnosis, prognosis, and potential treatment options for individuals suspected of having this rare genetic disorder. |